Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

Yonsei University

Status: Unknown

Conditions: Pediatrics

Treatments: Drug: remifentanil

Study type: Interventional

Funder types: Other

Identifiers

NCT01147757

4-2010-0129

Details and patient eligibility

About

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Enrollment: 60 estimated patients

Sex: All

Ages: 1 to 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy

Exclusion criteria

• cardiovascular, renal, liver disease or growth retardation

Trial design

60 participants in 4 patient groups, including a placebo group

saline

Placebo Comparator group

Description:

Group S (n = 15): saline

Treatment:

Drug: remifentanil

remifentanil 0.3 mcg/kg/min

Experimental group

Description:

Group 0.3 (n = 15): remifentanil 0.3 mcg/kg/min

Treatment:

Drug: remifentanil

remifentanil 0.6 mcg/kg/min

Experimental group

Description:

Group 0.6 (n = 15): remifentanil 0.6 mcg/kg/min

Treatment:

Drug: remifentanil

remifentanil 0.9 mcg/kg/min

Experimental group

Description:

Group 0.9 (n = 15): remifentanil 0.9 mcg/kg/min

Treatment:

Drug: remifentanil